News
PH clean power generation to reach 69.4 TWh in 2035
PH clean power generation to reach 69.4 TWh in 2035
The country’s renewable goals will be fuelled by geothermal and hydropower amongst others.
APAC eyes fastest growth in global body composition analysers market
The global market is projected to hit $935.8m by 2032.
SG banks leave more jobs unfilled as corporate spending pauses
For every two people who resign, only one post gets replaced.
APAC healthcare workers voice concerns over AI, data gaps
Over seven in ten are uncertain about legal liability in AI usage.
Asia sees sustained growth in construction insurance in 2024
However, insurers are pursuing profitability and program stability over the long term.
India life insurers post steady May growth despite policy volume drop
Annual Premium Equivalent by 14.4%.
1 in 3 Asian firms seek more trade with South Asia
Over 1 in 3 Asian companies are looking to trade more with South Asia and Europe whilst over 1 in 4 plan to trade less with North America, according to a 2025 survey by HSBC.
7MM atopic dermatitis market to be valued at $22.4b by 2033
The estimated drug-treated population may grow to over 25,100,000 people.
Companies move to avert cash-flow crisis
There is increased corporate demand for liquidity and risk coverage, says HSBC.
World’s installed renewable capacity to reach 11.2TW by 2035
Thanks to declining costs and policy support.
What factors drive the 7MM Angelman syndrome market?
The rare neurogenetic disorder affects around 500,000 people worldwide.
What lies ahead of the global healthcare transportation services market?
Digitalisation is shifting the sector to an integrated service ecosystem.
Asia’s insurance markets grow in 2024 on life, health gains
China led Asia’s life insurance recovery.
Medical cannabis market to hit $87.41b by 2030
The global advancement of its legislation is a key growth driver.
Over 85% of APAC’s energy generation comes from non-renewables
Reforms are needed to address the possible energy transition gap.
China’s biopharma sector strikes $30b in oncology licensing deals
Antibody-drug conjugates dominated licensing activity in 2024.
CEOs embrace venture-building to drive corporate innovation
Over half of CEOs now rank it among their top three priorities, according to McKinsey.
Commentary
Mobile-first web design: Why Asian brands can't afford to ignore it in 2025